[1]
B.M.S.R. Nayakar and Muddu Surendra Nehru, “To Evaluate the efficacy and safety profile of Rosuvastatin, Simvastatin and Atorvastatin in Newly Diagnosed Type 2 Diabetic patients with Dyslipidaemia”, Int. J. Heal. Clin. Res., vol. 4, no. 13, pp. 321–325, Jul. 2021.